[Direct oral anticoagulants: In which indications? Which one to prescribe? For or against their use in frail patients and in atypical cases? Which monitoring and management haemorrhage complications?]

La Revue de médecine interne
C HoffmannK Lacut

Abstract

Since their approval, the direct oral anticoagulants have been widely used in the management of venous thromboembolism, for stroke and systemic embolism prevention in non valvular atrial fibrillation, and in venous thromboembolism prophylaxis after surgical hip or knee replacement. Because they are easy to use, with oral fixed doses and no biological monitoring need, they are more and more prescribed. New indications are rising in cancer associated thrombosis in France beyond the 6 first months of treatment, and to prevent cardiovascular events after an acute coronary syndrome, or in stable coronary or peripheral arterial disease in Europe. The efficacity and safety of direct oral anticoagulants in frail patients or in unusual pathological contexts are not entirely known, but further data are coming and will probably bring new answers.

References

Jun 27, 2008·The New England Journal of Medicine·Bengt I ErikssonUNKNOWN RECORD1 Study Group
Jun 27, 2008·The New England Journal of Medicine·Michael R LassenUNKNOWN RECORD3 Investigators
Aug 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Marc A RodgerMichael J Kovacs
Aug 7, 2009·The New England Journal of Medicine·Michael Rud LassenRonald J Portman
Dec 24, 2010·The New England Journal of Medicine·Michael Rud LassenUNKNOWN ADVANCE-3 Investigators
Nov 15, 2011·The New England Journal of Medicine·Jessica L MegaUNKNOWN ATLAS ACS 2–TIMI 51 Investigators
Nov 23, 2011·Annales Françaises D'anesthèsie Et De Rèanimation·C-M SamamaUNKNOWN French Society of Anaesthesia and Intensive Care
Mar 28, 2012·The New England Journal of Medicine·Harry R BüllerAnnelise Segers
Dec 12, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY-EXT Investigators
Jul 3, 2013·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN AMPLIFY Investigators
Sep 3, 2013·The New England Journal of Medicine·John W EikelboomUNKNOWN RE-ALIGN Investigators
May 3, 2014·Journal of the American Geriatrics Society·Partha SardarGregory Y H Lip
Sep 13, 2014·Journal of the American College of Cardiology·Adam CukerDavid A Garcia
Sep 14, 2014·International Journal of Cardiology·Maria Cristina VedovatiGiancarlo Agnelli
Feb 5, 2015·Thrombosis Journal·Vincent GeldhofThomas Vanassche
Dec 25, 2015·The American Journal of Cardiology·Freddy Del-Carpio MunozPeter A Noseworthy
Jun 15, 2016·Journal of Thrombosis and Haemostasis : JTH·K MartinS Moll
Jul 20, 2016·Journal of Thrombosis and Haemostasis : JTH·C KearonUNKNOWN Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease
Oct 30, 2016·Thrombosis and Haemostasis·Aurélien DellucUNKNOWN EPIGETBO study group
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Mar 18, 2017·Journal of the American College of Cardiology·Giulia RendaRaffaele De Caterina
Mar 21, 2017·The New England Journal of Medicine·Jeffrey I WeitzUNKNOWN EINSTEIN CHOICE Investigators
Apr 12, 2017·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Raffaele De Caterina, Gregory Y H Lip
Aug 29, 2017·The New England Journal of Medicine·John W EikelboomUNKNOWN COMPASS Investigators
Dec 9, 2017·Mayo Clinic Proceedings·Dawid T JanczakWaldemar E Wysokinski
Dec 13, 2017·The New England Journal of Medicine·Gary E RaskobUNKNOWN Hokusai VTE Cancer Investigators
May 8, 2018·Anaesthesia Critical Care & Pain Medicine·Pierre AlbaladejoUNKNOWN members of the French Working Group on Perioperative Haemostasis
May 11, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annie M YoungMark Levine
Jun 7, 2018·Seminars in Interventional Radiology·Cécile TromeurFrederikus A Klok
Aug 28, 2018·Expert Review of Hematology·Georgia J B McCaughanJennifer Curnow
Aug 29, 2018·Thrombosis Research·Evert Willian HoolwerfNick van Es
Dec 5, 2018·The New England Journal of Medicine·Marc CarrierUNKNOWN AVERT Investigators

❮ Previous
Next ❯

Citations

May 1, 2021·International Journal of Environmental Research and Public Health·Patrick ManckoundiaAlain Putot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Paolo AlboniAndrea Ungar
Nederlands tijdschrift voor geneeskunde
Marcel Olde Rikkert, Jurgen Claassen
Journal of Thrombosis and Haemostasis : JTH
G Di Minno, A Tufano
© 2021 Meta ULC. All rights reserved